1. Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Intervent Radiol. 2011; 28:333–338.
2. Rockey DC. Management of gastric varices. Gastroenterology. 2001; 120:1875–1876. discussion 1876-1877
3. Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR Am J Roentgenol. 1984; 143:627–628.
4. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996; 11:51–58.
5. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics. 2003; 23:921–937. discussion 937
6. Saad WE, Simon PO Jr, Rose SC. Balloon-occluded retrograde transvenous obliteration of gastric varices. Cardiovasc Intervent Radiol. 2014; 37:299–315.
7. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001; 27:58–60.
8. Hamel-Desnos C, Allaert FA. Liquid versus foam sclerotherapy. Phlebology. 2009; 24:240–246.
9. Miura H, Yamagami T, Tanaka O, Yoshimatsu R. Portopulmonary venous anastomosis detected at balloon-occluded retrograde transvenous obliteration for gastric varices. J Vasc Interv Radiol. 2013; 24:131–134.
10. Kariya S, Komemushi A, Nakatani M, Yoshida R, Kono Y, Shiraishi T, et al. Portopulmonary venous anastomosis in balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices. J Gastroenterol Hepatol. 2014; 29:1522–1527.
11. Guex JJ. Complications and side-effects of foam sclerotherapy. Phlebology. 2009; 24:270–274.
12. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003; 14(9 Pt 2):S199–S202.
13. Kitamoto M, Imamura M, Kamada K, Aikata H, Kawakami Y, Matsumoto A, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol. 2002; 178:1167–1174.
14. Cameron E, Chen T, Connor DE, Behnia M, Parsi K. Sclerosant foam structure and stability is strongly influenced by liquid air fraction. Eur J Vasc Endovasc Surg. 2013; 46:488–494.
15. Saad WE, Nicholson D, Lippert A, Wagner CC, Turba CU, Sabri SS, et al. Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: incidence and consequences. Vasc Endovascular Surg. 2012; 46:664–670.
16. Alòs J, Carreño P, López JA, Estadella B, Serra-Prat M, Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg. 2006; 31:101–107.
17. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology. 2009; 24:131–138.
18. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006; 43:162–164.
19. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008; 358:1525–1526.
20. Schoenmackers J, Vieten H. [Portocaval and portopulmonary anastomoses in postmortem portography]. Fortschr Geb Rontgenstr. 1953; 79:488–498.
21. Asbjornsen CB, Rogers CD, Russell BL. Middle cerebral air embolism after foam sclerotherapy. Phlebology. 2012; 27:430–433.
22. Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, Salem O, et al. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002; 55:276–278.
23. Saracco G, Giordanino C, Roberto N, Ezio D, Luca T, Caronna S, et al. Fatal multiple systemic embolisms after injection of cyanoacrylate in bleeding gastric varices of a patient who was noncirrhotic but with idiopathic portal hypertension. Gastrointest Endosc. 2007; 65:345–347.
24. Gwon DI, Kim YH, Ko GY, Kim JW, Ko HK, Kim JH, et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol. 2015; 26:1589–1595.
25. Patel A, Fischman AM, Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices. AJR Am J Roentgenol. 2012; 199:721–729.
26. Hong CH, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 2009; 24:372–378.
27. Sabri SS, Swee W, Turba UC, Saad WE, Park AW, Al-Osaimi AM, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol. 2011; 22:309–316. quiz 316